Aron M. Troen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Aron M. Troen has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Jacob Selhub
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
6 shared publicationsIrwin H. Rosenberg
The Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, 711 Washington Street, Boston, MA 02111
4 shared publications- Barbara Shukitt-Hale
USDA-ARS, Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, USA
3 shared publications - Chao-Qiang Lai
USDA ARS, Precision Nutrition Team, JM-US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, USA
2 shared publications Donald E. Smith
Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, 711 Washington Street, Boston, MA 02111-1524
2 shared publicationsEmily E. French
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
2 shared publications
Latest Publications
- Open Access
- 9 February 2010
- Published by Springer Nature in AGE
- Vol. 32 (1) , 123
Erratum to: Lifespan modification by glucose and methionine in Drosophila melanogaster fed a chemically defined diet
- 9 February 2010
- Published by Springer Nature in AGE
- Vol. 32 (1) , 123
Open AccessErratum to: Lifespan modification by glucose and methionine in Drosophila melanogaster fed a chemically defined diet
- 1 December 2008
- Published by Elsevier in The Journal of Nutrition
- Vol. 138 (12) , 2502-2509
Cognitive Impairment in Folate-Deficient Rats Corresponds to Depleted Brain Phosphatidylcholine and Is Prevented by Dietary Methionine without Lowering Plasma Homocysteine
Poor folate status is associated with cognitive decline and dementia in older adults. Although impaired brain methylation activity and homocysteine to
- 1 December 2008
- Published by Elsevier in The Journal of Nutrition
- Vol. 138 (12) , 2502-2509
Cognitive Impairment in Folate-Deficient Rats Corresponds to Depleted Brain Phosphatidylcholine and Is Prevented by Dietary Methionine without Lowering Plasma Homocysteine
Poor folate status is associated with cognitive decline and dementia in older adults. Although impaired brain methylation activity and homocysteine to
- 26 August 2008
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (34) , 12474-12479
B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice
In older adults, mildly elevated plasma total homocysteine (hyperhomocysteinemia) is associated with increased risk of cognitive impairment, cerebrovascular disease, and Alzheimer's disease, but it is uncertain whether this is due to underlying metabolic, neurotoxic, or vascular processes. We report here that feeding male C57BL6/J mice a B-vitamin-deficient diet for 10 weeks induced hyperhomocysteinemia, significantly impaired spatial learning and memory, and caused a significant rarefaction of hippocampal microvasculature without concomitant gliosis and neurodegeneration. Total hippocampal capillary length was inversely correlated with Morris water maze escape latencies ( r = −0.757, P < 0.001), and with plasma total homocysteine ( r = −0.631, P = 0.007). Feeding mice a methionine-rich diet produced similar but less pronounced effects. Our findings suggest that cerebral microvascular rarefaction can cause cognitive dysfunction in the absence of or preceding neurodegeneration. Similar microvascular changes may mediate the association of hyperhomocysteinemia with human age-related cognitive decline.
- 26 August 2008
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 105 (34) , 12474-12479
B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice
In older adults, mildly elevated plasma total homocysteine (hyperhomocysteinemia) is associated with increased risk of cognitive impairment, cerebrovascular disease, and Alzheimer's disease, but it is uncertain whether this is due to underlying metabolic, neurotoxic, or vascular processes. We report here that feeding male C57BL6/J mice a B-vitamin-deficient diet for 10 weeks induced hyperhomocysteinemia, significantly impaired spatial learning and memory, and caused a significant rarefaction of hippocampal microvasculature without concomitant gliosis and neurodegeneration. Total hippocampal capillary length was inversely correlated with Morris water maze escape latencies ( r = −0.757, P < 0.001), and with plasma total homocysteine ( r = −0.631, P = 0.007). Feeding mice a methionine-rich diet produced similar but less pronounced effects. Our findings suggest that cerebral microvascular rarefaction can cause cognitive dysfunction in the absence of or preceding neurodegeneration. Similar microvascular changes may mediate the association of hyperhomocysteinemia with human age-related cognitive decline.
- 25 November 2006
- Published by Springer Nature in AGE
- Vol. 29 (1) , 29-39
Lifespan modification by glucose and methionine in Drosophila melanogaster fed a chemically defined diet
Experimentally restricting dietary calories, while maintaining adequate dietary nutrient content, extends lifespan in phylogenetically diverse species; thus suggesting the existence of conserved pathways which can modify lifespan in response to energy intake. However, in some cases the impact on longevity may depend on the quality of the energy source. In Drosophila, restriction of dietary yeast yields considerable lifespan extension whereas isocaloric restriction of dietary sugar yields only modest extension, indicating that other diet-responsive pathways can modify lifespan in this species. In rodents, restricting intake of a single amino acid – methionine – extends lifespan. Here we show that dietary methionine can modify lifespan in adult female, non-virgin Oregon-R strain Drosophila fed a chemically defined media. Compared to a diet containing 0.135% methionine and 15% glucose, high dietary methionine (0.405%) shortened maximum lifespan by 2.33% from 86 to 84 days and mean lifespan by 9.55% from 71.7 to 64.9 days. Further restriction of methionine to 0.045% did not extend maximum lifespan and shortened mean lifespan by 1.95% from 71.1 to 70.3 days. Restricting glucose from 15% to 5% while holding methionine at a concentration of 0.135%, modestly extended maximum lifespan by 5.8% from 86 to 91 days, without extending mean lifespan. All these diet-induced changes were highly significant (log-rank p < 0.0001). Notably, all four diets resulted in considerably longer life spans than those typically reported for flies fed conventional yeast and sugar based diets. Such defined diets can be used to identify lifespan-modifying pathways and specific gene-nutrient interactions in Drosophila.
- 25 November 2006
- Published by Springer Nature in AGE
- Vol. 29 (1) , 29-39
Lifespan modification by glucose and methionine in Drosophila melanogaster fed a chemically defined diet
Experimentally restricting dietary calories, while maintaining adequate dietary nutrient content, extends lifespan in phylogenetically diverse species; thus suggesting the existence of conserved pathways which can modify lifespan in response to energy intake. However, in some cases the impact on longevity may depend on the quality of the energy source. In Drosophila, restriction of dietary yeast yields considerable lifespan extension whereas isocaloric restriction of dietary sugar yields only modest extension, indicating that other diet-responsive pathways can modify lifespan in this species. In rodents, restricting intake of a single amino acid – methionine – extends lifespan. Here we show that dietary methionine can modify lifespan in adult female, non-virgin Oregon-R strain Drosophila fed a chemically defined media. Compared to a diet containing 0.135% methionine and 15% glucose, high dietary methionine (0.405%) shortened maximum lifespan by 2.33% from 86 to 84 days and mean lifespan by 9.55% from 71.7 to 64.9 days. Further restriction of methionine to 0.045% did not extend maximum lifespan and shortened mean lifespan by 1.95% from 71.1 to 70.3 days. Restricting glucose from 15% to 5% while holding methionine at a concentration of 0.135%, modestly extended maximum lifespan by 5.8% from 86 to 91 days, without extending mean lifespan. All these diet-induced changes were highly significant (log-rank p < 0.0001). Notably, all four diets resulted in considerably longer life spans than those typically reported for flies fed conventional yeast and sugar based diets. Such defined diets can be used to identify lifespan-modifying pathways and specific gene-nutrient interactions in Drosophila.
- 7 August 2006
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 9 (4) , 381-392
The cognitive impact of nutritional homocysteinemia in Apolipoprotein-E deficient mice
Homocysteinemia is associated with cognitive dysfunction in the elderly ranging from subtle cognitive decline to dementia. Homocysteine is generated from methionine as a product of biological methylation reactions and is disposed of through reactions
- 7 August 2006
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 9 (4) , 381-392
The cognitive impact of nutritional homocysteinemia in Apolipoprotein-E deficient mice
Homocysteinemia is associated with cognitive dysfunction in the elderly ranging from subtle cognitive decline to dementia. Homocysteine is generated from methionine as a product of biological methylation reactions and is disposed of through reactions
- 1 September 2005
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 29 (7) , 1140-1151
The central nervous system in animal models of hyperhomocysteinemia
- 1 September 2005
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 29 (7) , 1140-1151
The central nervous system in animal models of hyperhomocysteinemia
- 9 December 2003
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 100 (25) , 15089-15094
The atherogenic effect of excess methionine intake
Methionine is the precursor of homocysteine, a sulfur amino acid intermediate in the methylation and transsulfuration pathways. Elevated plasma homocysteine (hyperhomocysteinemia) is associated with occlusive vascular disease. Whether homocysteine per se or a coincident metabolic abnormality causes vascular disease is still an open question. Animals with genetic hyperhomocysteinemia have so far not displayed atheromatous lesions. However, when methionine-rich diets are used to induce hyperhomocysteinemia, vascular pathology is often observed. Such studies have not distinguished the effects of excess dietary methionine from those of hyperhomocysteinemia. We fed apolipoprotein E-deficient mice with experimental diets designed to achieve three conditions: ( i ) high methionine intake with normal blood homocysteine; ( ii ) high methionine intake with B vitamin deficiency and hyperhomocysteinemia; and ( iii ) normal methionine intake with B vitamin deficiency and hyperhomocysteinemia. Mice fed methionine-rich diets had significant atheromatous pathology in the aortic arch even with normal plasma homocysteine levels, whereas mice fed B vitamin-deficient diets developed severe hyperhomocysteinemia without any increase in vascular pathology. Our findings suggest that moderate increases in methionine intake are atherogenic in susceptible mice. Although homocysteine may contribute to the effect of methionine, high plasma homocysteine was not independently atherogenic in this model. Some product of excess methionine metabolism rather than high plasma homocysteine per se may underlie the association of homocysteine with vascular disease.
- 9 December 2003
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 100 (25) , 15089-15094
The atherogenic effect of excess methionine intake
Methionine is the precursor of homocysteine, a sulfur amino acid intermediate in the methylation and transsulfuration pathways. Elevated plasma homocysteine (hyperhomocysteinemia) is associated with occlusive vascular disease. Whether homocysteine per se or a coincident metabolic abnormality causes vascular disease is still an open question. Animals with genetic hyperhomocysteinemia have so far not displayed atheromatous lesions. However, when methionine-rich diets are used to induce hyperhomocysteinemia, vascular pathology is often observed. Such studies have not distinguished the effects of excess dietary methionine from those of hyperhomocysteinemia. We fed apolipoprotein E-deficient mice with experimental diets designed to achieve three conditions: ( i ) high methionine intake with normal blood homocysteine; ( ii ) high methionine intake with B vitamin deficiency and hyperhomocysteinemia; and ( iii ) normal methionine intake with B vitamin deficiency and hyperhomocysteinemia. Mice fed methionine-rich diets had significant atheromatous pathology in the aortic arch even with normal plasma homocysteine levels, whereas mice fed B vitamin-deficient diets developed severe hyperhomocysteinemia without any increase in vascular pathology. Our findings suggest that moderate increases in methionine intake are atherogenic in susceptible mice. Although homocysteine may contribute to the effect of methionine, high plasma homocysteine was not independently atherogenic in this model. Some product of excess methionine metabolism rather than high plasma homocysteine per se may underlie the association of homocysteine with vascular disease.